Wilmington Health Pulmonary and Allergy Now an Alpha-1 Foundation Clinical Resource Center

Share Article

PMG Research of Wilmington partner Wilmington Health receives designation as a Clinical Resource Center for those with Alpha-1 Antitrypsin Deficiency (Alpha-1).

Through the new foundation, we will offer testing and new treatments for the condition, which will allow for earlier diagnoses for patients.

PMG Research, Inc. announced today that Wilmington, NC partner Wilmington Health Pulmonary and Allergy is now an Alpha-1 Foundation Clinical Resource Center. A Clinical Resource Center (CRC) is one of more than 70 centers throughout North America that specialize in patient care and education for those with Alpha-1 Antitrypsin Deficiency (Alpha-1). Wilmington Health Pulmonary and Allergy is one of the select CRCs that also performs Alpha-1 research.

At a CRC, Alphas can see a physician familiar with Alpha-1 and get answers about their condition. They can also find out more about how Alpha-1 affects their families and learn about the testing choices available to family members. Each center must meet certain criteria in order to be listed as a CRC through the Foundation.

Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic condition that can affect individuals of all ages. It can result in serious lung and/or liver disease. Alpha-1 affects all populations and ethnic groups. According to the Alpha-1 Foundation, one in every 2,500 Americans has Alpha-1.

“We are very excited to become the only Alpha-1 Foundation Clinical Resource Center in the area,” said Wilmington Health’s Douglas Lee, MD, FCCP. “Through the new foundation, we will offer testing and new treatments for the condition, which will allow for earlier diagnoses for patients. An early diagnosis will offer a patient various lifestyle benefits.”

Alpha-1 patients with lung disease will most likely have the following symptoms: shortness of breath, wheezing, recurring chest colds, chronic bronchitis, and more. Unexplained liver disease, jaundice, and swelling of the abdomen are symptoms associated with Alpha-1 patients with liver disease. If you or someone you know has these symptoms, find out how you can make an appointment at the Wilmington Health Alpha-1 Foundation Clinical Resource Center by calling (910) 341-3458. Anyone interested in learning more about clinical research participation should visit http://www.PMGofWilmington.com or call (910) 815-6108.

###

About PMG Research, Inc.
PMG Research, Inc. is an Integrated Site Network (ISN) of clinical research facilities in the southeast region of the United States with locations in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Bristol and Knoxville, TN; and Charleston, SC. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Since 1979, PMG has conducted over 6,000 research studies for more than 100 pharmaceutical sponsors and CROs. Our progressive organization is comprised of a team of highly effective professionals and a network of specially-designed sites. Our mission as an ISN is to provide unparalleled service to our clinical trial partners. We commit to progress, integrity and excellence. For more information about PMG Research, please visit http://www.pmg-research.com.

About the Alpha-1 Foundation
The Alpha-1 Foundation is dedicated to providing the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1 Antitrypsin Deficiency. The Foundation has invested nearly $47 million to support Alpha-1 research at 94 institutions in North America, Europe, the Middle East and Australia. For more information, please visit http://www.alpha-1foundation.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amanda Wright
Follow us on
Visit website